massachusetts institute of technology

Doxorubicin

One-two punch knocks out aggressive breast cancer cells
One-two punch knocks out aggressive breast cancer cells
May 11, 2012
New MIT study shows that staggered delivery of cancer drugs is far more effective than administering them at the same time.
Also labeled: Biology, Cancer, Koch Institute, Breast cancer, Erlotinib
RSS Subscribe